These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

101 related articles for article (PubMed ID: 26598221)

  • 21. Preclinical testing of drug delivery systems to bone.
    van Griensven M
    Adv Drug Deliv Rev; 2015 Nov; 94():151-64. PubMed ID: 26212157
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Silica-based mesoporous nanobiomaterials as promoter of bone regeneration process.
    Shadjou N; Hasanzadeh M
    J Biomed Mater Res A; 2015 Nov; 103(11):3703-16. PubMed ID: 26011776
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Drug-eluting scaffolds for bone and cartilage regeneration.
    Huang CL; Lee WL; Loo JS
    Drug Discov Today; 2014 Jun; 19(6):714-24. PubMed ID: 24239726
    [TBL] [Abstract][Full Text] [Related]  

  • 24. High biocompatibility and improved osteogenic potential of novel Ca-P/titania composite scaffolds designed for regeneration of load-bearing segmental bone defects.
    Cunha C; Sprio S; Panseri S; Dapporto M; Marcacci M; Tampieri A
    J Biomed Mater Res A; 2013 Jun; 101(6):1612-9. PubMed ID: 23172612
    [TBL] [Abstract][Full Text] [Related]  

  • 25. From natural bone grafts to tissue engineering therapeutics: Brainstorming on pharmaceutical formulative requirements and challenges.
    Baroli B
    J Pharm Sci; 2009 Apr; 98(4):1317-75. PubMed ID: 18729202
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Vascularization of repaired limb bone defects using chitosan-β-tricalcium phosphate composite as a tissue engineering bone scaffold.
    Yang L; Wang Q; Peng L; Yue H; Zhang Z
    Mol Med Rep; 2015 Aug; 12(2):2343-7. PubMed ID: 25902181
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Functionalizing mesoporous bioglasses for long-term anti-osteoporotic drug delivery.
    López-Noriega A; Arcos D; Vallet-Regí M
    Chemistry; 2010 Sep; 16(35):10879-86. PubMed ID: 20661959
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Investigation of emulsified, acid and acid-alkali catalyzed mesoporous bioactive glass microspheres for bone regeneration and drug delivery.
    Miao G; Chen X; Dong H; Fang L; Mao C; Li Y; Li Z; Hu Q
    Mater Sci Eng C Mater Biol Appl; 2013 Oct; 33(7):4236-43. PubMed ID: 23910338
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Biodegradable effect of PLGA membrane in alveolar bone regeneration on beagle dog.
    Hua N; Ti VL; Xu Y
    Cell Biochem Biophys; 2014 Nov; 70(2):1051-5. PubMed ID: 24833431
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Growth factor delivery for bone tissue repair: an update.
    Varkey M; Gittens SA; Uludag H
    Expert Opin Drug Deliv; 2004 Nov; 1(1):19-36. PubMed ID: 16296718
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Bone regeneration in allogenic dental grafts and alloplastic implants. Histological and ultrastructural research].
    Franchi M; Vernole B; Cantoni E; Evangelisti A; Ruggeri A
    Mondo Odontostomatol; 1987; 29(2):19-27. PubMed ID: 2444876
    [No Abstract]   [Full Text] [Related]  

  • 32. [Histologic and histomorphometric study of bone regeneration induced by beta-tricalcium phosphate (multicenter study)].
    Suba Z; Hrabák K; Huys L; Coulthard P; Maiorana C; Garagiola U; Szabó G
    Orv Hetil; 2004 Jul; 145(27):1431-7. PubMed ID: 15320486
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Local delivery of small and large biomolecules in craniomaxillofacial bone.
    Ji W; Wang H; van den Beucken JJ; Yang F; Walboomers XF; Leeuwenburgh S; Jansen JA
    Adv Drug Deliv Rev; 2012 Sep; 64(12):1152-64. PubMed ID: 22429663
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Strategies to engineer tendon/ligament-to-bone interface: Biomaterials, cells and growth factors.
    Font Tellado S; Balmayor ER; Van Griensven M
    Adv Drug Deliv Rev; 2015 Nov; 94():126-40. PubMed ID: 25777059
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Osteoconductivity of strontium-doped bioactive glass particles: a histomorphometric study in rats.
    Gorustovich AA; Steimetz T; Cabrini RL; Porto López JM
    J Biomed Mater Res A; 2010 Jan; 92(1):232-7. PubMed ID: 19172615
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Fundamental principles of bioreactive implant materials].
    Newesely H
    Zahn Mund Kieferheilkd Zentralbl; 1984; 72(3):230-9. PubMed ID: 6236644
    [No Abstract]   [Full Text] [Related]  

  • 37. Comment on "A novel strategy for prefabrication of large and axially vascularized tissue engineered bone by using an arteriovenous loop".
    Jiang X; Wang D; Jin D; Pei G
    Med Hypotheses; 2009 Sep; 73(3):461-2. PubMed ID: 19409712
    [No Abstract]   [Full Text] [Related]  

  • 38. Bioactive factors and biosynthetic materials in bone grafting.
    Hollinger JO; Seyfer AE
    Clin Plast Surg; 1994 Jul; 21(3):415-8. PubMed ID: 7924139
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Comparative experimental animal studies on bone regeneration after implantation of various calcium phosphate ceramics].
    Wagner W; Wahlmann UW
    Dtsch Zahnarztl Z; 1985 Jun; 40(6):664-7. PubMed ID: 3868572
    [No Abstract]   [Full Text] [Related]  

  • 40. Matrices and scaffolds for delivery of bioactive molecules in bone and cartilage tissue engineering.
    Lee SH; Shin H
    Adv Drug Deliv Rev; 2007 May; 59(4-5):339-59. PubMed ID: 17499384
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.